Welcome to our dedicated page for Crh Plc SEC filings (Ticker: CRH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
CRH Public Limited Company filings document the building materials company's operating results, governance matters, capital structure, and material events. Annual reports on Form 10-K cover audited financial statements and business disclosures, while 8-K filings report material events and securities registered under the Exchange Act.
Proxy filings describe annual general meeting matters, shareholder votes, board governance, executive compensation, and related ownership disclosures. CRH's registered securities include ordinary shares on the New York Stock Exchange and multiple NYSE-listed notes with maturities extending from 2029 through 2056.
CRH Public Ltd Co director Siobhan Talbot reported several equity compensation-related transactions. On May 13, 2026, time-based restricted share units vested and were converted into 1,976 Ordinary Shares, with 1,047 Ordinary Shares withheld to cover tax liabilities, a non-market disposition.
Talbot also received a new time-based award of 1,556 Restricted Share Units under the CRH plc 2025 Equity Incentive Plan, each RSU representing one Ordinary Share and scheduled to vest in May 2027. Following these transactions, Talbot holds 9,554 Ordinary Shares directly.
CRH PUBLIC LTD CO executive Peter J. Buckley reported routine equity compensation activity. On May 13, 2026, 3,439 restricted share units vested and converted into Ordinary Shares, representing one-third of a 10,317-unit award granted under the CRH plc Equity Incentive Plan, including 48 dividend-equivalent shares. To cover withholding taxes arising from this vesting, 1,742 Ordinary Shares were mandatorily sold at a volume-weighted average price of $110.4333 per share, with sale prices ranging from $109.2007 to $111.515. Following these transactions, Buckley directly holds 171,415 Ordinary Shares and 16,051 restricted share units, with the remaining two thirds of the original award scheduled to vest in May 2027 and May 2028.
CRH PUBLIC LTD CO director Richard H. Fearon reported routine equity compensation activity. On May 13, 2026, 1,976 restricted share units vested and were converted into Ordinary Shares, while 962 Ordinary Shares were withheld at $108.75 per share to cover related tax liabilities. Following these transactions, Fearon directly holds 145,804 Ordinary Shares. He also received a new grant of 1,556 restricted share units under the CRH plc 2025 Equity Incentive Plan, which is scheduled to vest in May 2027 and will accrue dividend equivalents until vesting.
CRH PUBLIC LTD CO director Shaun Kelly reported equity compensation activity. On May 13, 2026, he exercised 1,976 Restricted Share Units into Ordinary Shares and had 962 Ordinary Shares withheld at $108.75 per share to cover tax liabilities related to this vesting.
Following these transactions, he directly held 5,042 Ordinary Shares. Kelly also received a new time-based conditional award of 1,556 Restricted Share Units under the CRH plc 2025 Equity Incentive Plan, each representing one Ordinary Share, scheduled to fully vest in May 2027.
CRH PUBLIC LTD CO Chief Development Officer Philip Wheatley reported routine equity compensation activity. On May 13, 2026, a time-based award of 5,928 restricted share units granted on May 13, 2025 partially vested, releasing 1,976 ordinary shares, including 27 dividend-equivalent shares. In connection with this vesting, 1,046 ordinary shares were mandatorily disposed of to cover withholding tax liabilities at a volume-weighted average price of $110.4137 per share, with sale prices ranging from $109.02 to $111.515. Following these transactions, Wheatley directly holds 53,045 ordinary shares and 8,428 restricted share units, with the remaining thirds of the award scheduled to vest on grant anniversaries in May 2027 and May 2028.
CRH public limited company appointed Aylwyn Bryan as Chief Financial Officer, effective May 12, 2026, succeeding Nancy Buese, who stepped down by mutual agreement. The company states her departure is not due to any disagreement on operations, policies or practices.
Bryan, a 14-year CRH executive and former CFO of the Americas Division, will receive an initial annual base salary of $850,000, with a target annual bonus equal to 100% of base salary and a maximum of 200%. He also receives a monthly taxable pension cash adjustment equal to 10% of annual base salary and is eligible for future equity awards.
In connection with the promotion, Bryan will receive a one-time long-term equity incentive award of $1,563,000, granted 60% in performance stock units and 40% in restricted share units. On certain terminations within six months after a change of control, he may receive severance equal to two years of base salary plus vested incentives. Buese will remain as a non-executive employee through August 11, 2026 to support an orderly transition.
CRH Public Ltd Co Chief Financial Officer Bryan Aylwyn has filed an initial ownership report showing direct holdings of 16,286 Ordinary Shares. He also holds 6,678 Restricted Share Units granted under the CRH plc Equity Incentive Plan, which vest in equal annual thirds over three years.
CRH public limited company filed a Form 144 notifying a proposed disposition of 632 ordinary shares (Euro 0.32 par value) tied to the vesting of a time-based equity award with a proposed sale date of 05/13/2026. The filing lists Fidelity Brokerage Services LLC as the broker.
CRH public limited company submitted a Rule 144 notice relating to proposed transfers of Ordinary Shares of Euro 0.32 each, linked to the vesting of a time-based equity award with an effective date of 05/13/2026. The filing records an earlier sale of 7,502 shares on 02/23/2026 and shows a current reported quantity of 7,932 shares tied to the vesting event.
CRH public limited company reported the results of its 2026 Annual General Meeting. Shareholders re-elected all 12 director nominees, each receiving over 506 million votes in favor in most cases, confirming broad support for the existing board.
Investors also approved, on an advisory basis, 2025 executive compensation, with 494,527,037 votes for and 33,803,416 against. They ratified Deloitte & Touche LLP and related Deloitte firms as auditors and authorized the Audit Committee to set their compensation. The meeting renewed annual authorities for the board to issue ordinary shares, issue shares for cash without first offering them to existing shareholders, repurchase shares on the market, and re-issue treasury shares.
Shareholders further backed a series of changes related to the Company’s preference shares, including schemes of arrangement to cancel the 5% cumulative and 7% “A” cumulative preference shares, a related reduction of capital, and amendments to CRH’s Memorandum and Articles of Association. They also approved deleting the director qualification shareholding requirement from the Articles.